A critical review to identify data gaps and improve risk assessment of bisphenol A alternatives for human health

Crit Rev Toxicol. 2024 Nov;54(10):696-753. doi: 10.1080/10408444.2024.2388712. Epub 2024 Oct 22.

Abstract

Bisphenol A (BPA), a synthetic chemical widely used in the production of polycarbonate plastic and epoxy resins, has been associated with a variety of adverse effects in humans including metabolic, immunological, reproductive, and neurodevelopmental effects, raising concern about its health impact. In the EU, it has been classified as toxic to reproduction and as an endocrine disruptor and was thus included in the candidate list of substances of very high concern (SVHC). On this basis, its use has been banned or restricted in some products. As a consequence, industries turned to bisphenol alternatives, such as bisphenol S (BPS) and bisphenol F (BPF), which are now found in various consumer products, as well as in human matrices at a global scale. However, due to their toxicity, these two bisphenols are in the process of being regulated. Other BPA alternatives, whose potential toxicity remains largely unknown due to a knowledge gap, have also started to be used in manufacturing processes. The gradual restriction of the use of BPA underscores the importance of understanding the potential risks associated with its alternatives to avoid regrettable substitutions. This review aims to summarize the current knowledge on the potential hazards related to BPA alternatives prioritized by European Regulatory Agencies based on their regulatory relevance and selected to be studied under the European Partnership for the Assessment of Risks from Chemicals (PARC): BPE, BPAP, BPP, BPZ, BPS-MAE, and TCBPA. The focus is on data related to toxicokinetic, endocrine disruption, immunotoxicity, developmental neurotoxicity, and genotoxicity/carcinogenicity, which were considered the most relevant endpoints to assess the hazard related to those substances. The goal here is to identify the data gaps in BPA alternatives toxicology and hence formulate the future directions that will be taken in the frame of the PARC project, which seeks also to enhance chemical risk assessment methodologies using new approach methodologies (NAMs).

Keywords: Bisphenol A alternatives; carcinogenesis; developmental neurotoxicity; endocrine disruption; genotoxicity; human health; immunotoxicity; metabolism; toxicokinetic.

Publication types

  • Review

MeSH terms

  • Animals
  • Benzhydryl Compounds* / toxicity
  • Endocrine Disruptors* / toxicity
  • Humans
  • Phenols* / toxicity
  • Risk Assessment / methods
  • Sulfones / toxicity

Substances

  • Phenols
  • Benzhydryl Compounds
  • bisphenol A
  • Endocrine Disruptors
  • bisphenol S
  • bisphenol F
  • Sulfones